FIGURE 4.
The prognostic value of the signature for ESCA. (A) Univariate Cox analysis based on age, gender, stage, and risk scores. (B) Multivariate Cox analysis based on age, gender, stage, and risk scores. (C) Comparison of the predictive accuracy of risk models and clinicopathological characteristics. (D) ROC of the risk characteristic based on a whole-group prediction of 1, 3, and 5-year OS.
